Upstream Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	360	1,473	881	-	-
Market Cap Growth	-50.87%	67.10%	-	-	-
Enterprise Value	65.16	1,132	412.62	0	0
Last Close Price	6.62	27.15	16.44	-	-
PS Ratio	107.96	515.96	371.83	-	-
PB Ratio	1.15	4.33	1.88	-	-
P/TBV Ratio	1.18	4.30	0.48	-	-
EV/Sales Ratio	19.62	396.75	174.10	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.96	-1.00	-1.00	0.87	0.16
Net Debt / EBITDA Ratio	1.71	2.12	6.03	2.67	0.71
Net Debt / FCF Ratio	2.10	2.55	7.85	2.81	0.89
Asset Turnover	0.01	0.01	0.01	0.04	0.07
Quick Ratio	21.63	25.44	43.87	16.87	3.60
Current Ratio	23.14	26.15	44.63	17.96	3.77
Return on Equity (ROE)	-48.70%	-35.43%	-17.92%	-11.95%	-21.16%
Return on Assets (ROA)	-51.19%	-38.39%	-25.97%	-59.13%	-129.39%
Return on Invested Capital (ROIC)	-2600.57%	-5383.05%	-3719.88%	-6822.11%	-9267.05%
Return on Capital Employed (ROCE)	-53.35%	-39.53%	-26.74%	-64.54%	-175.52%
Buyback Yield / Dilution	-105.15%	-293.59%	-363.22%	-0.56%	-
Total Shareholder Return	-105.15%	-293.59%	-363.22%	-0.56%	-

SEC Filings: 10-K · 10-Q